LASS3 抗体 (AA 301-382) (HRP)
Quick Overview for LASS3 抗体 (AA 301-382) (HRP) (ABIN7090972)
抗原
See all LASS3 (CERS3) 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 301-382
- 
                                            交叉反应
- 小鼠, 大鼠
- 
                                            纯化方法
- Purified by Protein A.
- 
                                            免疫原
- KLH conjugated synthetic peptide derived from mouse LASS3
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- WB 1:300-5000
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            浓度
- 1 μg/μL
- 
                                            缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
 
- 
                                            
- 
    - LASS3 (CERS3) (Ceramide Synthase 3 (CERS3))
- 
                                            别名
- LASS3
- 
                                            背景
- 
                        Synonyms: LAG1 longevity assurance homolog 3, CerS3, LAG1 homolog, ceramide synthase 3, LASS 3, MGC 27091, CERS3_HUMAN. Background: May be involved in sphingolipid synthesis or its regulation 
- 
                                            基因ID
- 545975
- 
                                            UniProt
- Q3V1D5
 抗原
- 
                    
 
                                     
                                     
                                    